Stock Analyses
Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.
All sectors 6,478
Financial Services 1,900
Healthcare 1,116
Technology 1,078
Industrials 668
Consumer Cyclical 490
Basic Materials 337
Consumer Defensive 248
Communication Services 213
Utilities 183
Energy 165
Real Estate 80
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
OMF
Deeply undervalued
OneMain Holdings, Inc.
Price$62.75
Model IV$166.11
P/IV0.33
Discount 62%
Return to IV: +164.7%
Market implies -21.6%/yr
vs model -4.4% · below model
OMH
Deeply overvalued
Ohmyhome Ltd
Price$2.22
Model IV$1.32
P/IV0.62
Premium +68%
Return to IV: -40.5%
Market implies -4.6%/yr
vs model +15.0% · below model
OMSE
Valuation N/A
OMS Energy Technologies Inc.
Price$4.43
Model IV—
P/IV—
ON
Valuation N/A
ON SEMICONDUCTOR CORP
Price$69.98
Model IV—
P/IV—
Owner yield 3.6%
10-yr IRR 2.8% · steady
Market implies +21.8%/yr
vs model +4.9% · above model
ONB
Overvalued
OLD NATIONAL BANCORP /IN/
Price$25.66
Model IV$20.39
P/IV1.18
Premium +26%
Return to IV: -20.5%
ONBPO
Fairly valued
OLD NATIONAL BANCORP /IN/
Price$24.77
Model IV$23.13
P/IV1.08
Premium +7%
Return to IV: -6.6%
ONBPP
Fairly valued
OLD NATIONAL BANCORP /IN/
Price$24.80
Model IV$23.13
P/IV1.07
Premium +7%
Return to IV: -6.7%
ONC
Valuation N/A
BeOne Medicines Ltd.
Price$346.51
Model IV—
P/IV—
Market implies +22.7%/yr
vs model +46.0% · below model
ONCH
Valuation N/A
1RT Acquisition Corp.
Price$10.32
Model IV—
P/IV—
ONCHU
Valuation N/A
1RT Acquisition Corp.
Price$10.44
Model IV—
P/IV—
ONCHW
Valuation N/A
1RT Acquisition Corp.
Price$0.49
Model IV—
P/IV—
ONCO
Fairly valued
Onconetix, Inc.
Price$0.65
Model IV$0.65
P/IV1.84
Discount 1%
Return to IV: +1.1%
Market implies -3.5%/yr
vs model +15.0% · below model
ONCY
Valuation N/A
ONCOLYTICS BIOTECH INC
Price$0.75
Model IV—
P/IV—
ONDS
Valuation N/A
Ondas Inc.
Price$7.23
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +50.0% · below model
ONEG
Undervalued
OneConstruction Group Ltd
Price$1.03
Model IV$1.13
P/IV0.82
Discount 9%
Return to IV: +10.0%
Market implies -4.3%/yr
vs model +2.0% · below model
ONEW
Valuation N/A
OneWater Marine Inc.
Price$10.73
Model IV—
P/IV—
ONFO
Deeply undervalued
Onfolio Holdings, Inc
Price$0.85
Model IV$11.30
P/IV0.06
Discount 93%
Return to IV: +1,237.6%
Market implies -50.0%/yr
vs model +50.0% · below model
ONFOW
Valuation N/A
Onfolio Holdings, Inc
Price$0.02
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +50.0% · below model
ONIT
Valuation N/A
ONITY GROUP INC.
Price$34.34
Model IV—
P/IV—
Market implies +23.2%/yr
vs model +7.9% · above model
ONL
Deeply overvalued
Orion Properties Inc.
Price$2.56
Model IV$1.32
P/IV2.26
Premium +94%
Return to IV: -48.5%
ONMD
Valuation N/A
OneMedNet Corp
Price$0.65
Model IV—
P/IV—
Market implies +63.7%/yr
vs model +15.0% · above model
ONMDW
Valuation N/A
OneMedNet Corp
Price$0.03
Model IV—
P/IV—
Market implies +15.0%/yr
vs model +2.0% · above model
ONON
Valuation N/A
On Holding AG
Price$27.47
Model IV—
P/IV—
ONT
Fairly valued
Onterris, Inc.
Price$17.80
Model IV$19.06
P/IV0.84
Discount 7%
Return to IV: +7.1%
Market implies +5.7%/yr
vs model +9.5% · below model
ONTO
Valuation N/A
ONTO INNOVATION INC.
Price$281.26
Model IV—
P/IV—
Owner yield 1.6%
10-yr IRR -7.6% · steady
Market implies +30.8%/yr
vs model +3.0% · above model
OOMA
Deeply overvalued
OOMA INC
Price$22.77
Model IV$4.96
P/IV3.56
Premium +359%
Return to IV: -78.2%
Market implies +28.0%/yr
vs model +10.1% · above model
OPAD
Deeply undervalued
Offerpad Solutions Inc.
Price$3.57
Model IV$6.98
P/IV0.69
Discount 49%
Return to IV: +95.5%
Market implies -27.4%/yr
vs model -10.0% · below model
OPAL
Deeply overvalued
OPAL Fuels Inc.
Price$1.89
Model IV$0.65
P/IV3.50
Premium +193%
Return to IV: -65.8%
OPBK
Fairly valued
OP Bancorp
Price$15.40
Model IV$17.14
P/IV0.82
Discount 10%
Return to IV: +11.3%
OPCH
Deeply undervalued
Option Care Health, Inc.
Price$23.99
Model IV$49.43
P/IV0.42
Discount 51%
Return to IV: +106.0%
Owner yield 7.1%
10-yr IRR 20.3% · grower
Market implies +2.3%/yr
vs model +14.8% · below model
OPEN
Deeply undervalued
Opendoor Technologies Inc.
Price$2.65
Model IV$4.93
P/IV1.02
Discount 46%
Return to IV: +86.0%
Owner yield 44.7%
10-yr IRR 43.7% · steady
Market implies -20.9%/yr
vs model -8.7% · below model
OPENL
Valuation N/A
Opendoor Technologies Inc.
Price$0.10
Model IV—
P/IV—
Market implies -50.0%/yr
vs model -8.7% · below model
OPENW
Valuation N/A
Opendoor Technologies Inc.
Price$0.16
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +8.2% · below model
OPENZ
Valuation N/A
Opendoor Technologies Inc.
Price$0.09
Model IV—
P/IV—
Market implies -50.0%/yr
vs model -8.7% · below model
OPFI
Valuation N/A
OppFi Inc.
Price$7.98
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +13.2% · below model
OPHC
Deeply undervalued
OptimumBank Holdings, Inc.
Price$9.20
Model IV$13.40
P/IV0.41
Discount 31%
Return to IV: +45.6%
OPK
Deeply overvalued
OPKO HEALTH, INC.
Price$1.57
Model IV$0.43
P/IV3.41
Premium +267%
Return to IV: -72.8%
Market implies +15.8%/yr
vs model +2.0% · above model
OPLN
Deeply undervalued
OPENLANE, Inc.
Price$35.28
Model IV$63.70
P/IV0.60
Discount 45%
Return to IV: +80.6%
Owner yield 6.7%
10-yr IRR 16.4% · moderate
Market implies +0.7%/yr
vs model +11.1% · below model
OPP
Valuation N/A
RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.
Price$7.36
Model IV—
P/IV—
OPRA
Valuation N/A
Opera Ltd
Price$18.30
Model IV—
P/IV—
OPRT
Valuation N/A
Oportun Financial Corp
Price$7.87
Model IV—
P/IV—
Market implies -43.9%/yr
vs model +24.9% · below model
OPRX
Undervalued
OptimizeRx Corp
Price$7.29
Model IV$6.95
P/IV0.75
Premium +5%
Return to IV: -4.6%
Market implies +8.0%/yr
vs model +12.0% · below model
OPTH
Valuation N/A
Optimi Health Corp.
Price$5.07
Model IV—
P/IV—
OPTT
Deeply overvalued
Ocean Power Technologies, Inc.
Price$2.73
Model IV$0.64
P/IV4.25
Premium +325%
Return to IV: -76.5%
OPTU
Valuation N/A
Optimum Communications, Inc.
Price$1.02
Model IV—
P/IV—
Owner yield 10.6%
10-yr IRR 14.4% · steady
Market implies -50.0%/yr
vs model +0.0% · below model
OPTX
Valuation N/A
SYNTEC OPTICS HOLDINGS, INC.
Price$7.10
Model IV—
P/IV—
Market implies +47.4%/yr
vs model +2.0% · above model
OPTXW
Valuation N/A
SYNTEC OPTICS HOLDINGS, INC.
Price$1.26
Model IV—
P/IV—
OPXS
Deeply undervalued
Optex Systems Holdings Inc
Price$10.21
Model IV$21.56
P/IV0.53
Discount 53%
Return to IV: +111.2%
Owner yield 3.2%
10-yr IRR 8.9% · grower
Market implies +4.4%/yr
vs model +22.9% · below model
OPY
Deeply undervalued
OPPENHEIMER HOLDINGS INC
Price$119.48
Model IV$218.33
P/IV0.42
Discount 45%
Return to IV: +82.7%
Market implies -3.5%/yr
vs model +7.0% · below model
OR
Valuation N/A
OR Royalties Inc.
Price$36.03
Model IV—
P/IV—
ORA
Valuation N/A
ORMAT TECHNOLOGIES, INC.
Price$94.89
Model IV—
P/IV—
ORBS
Deeply overvalued
Eightco Holdings Inc.
Price$0.86
Model IV$0.62
P/IV1.49
Premium +38%
Return to IV: -27.5%
Market implies +11.3%/yr
vs model +43.1% · below model
ORC
Valuation N/A
Orchid Island Capital, Inc.
Price$6.33
Model IV—
P/IV—
ORCL
Valuation N/A
ORACLE CORP
Price$147.61
Model IV—
P/IV—
Market implies +25.2%/yr
ORGN
Valuation N/A
Origin Materials, Inc.
Price$0.95
Model IV—
P/IV—
Market implies +35.9%/yr
vs model +0.0% · above model
ORGNW
Valuation N/A
Origin Materials, Inc.
Price$0.00
Model IV—
P/IV—
Market implies -50.0%/yr
vs model +8.0% · below model
ORGO
Deeply undervalued
Organogenesis Holdings Inc.
Price$1.46
Model IV$3.46
P/IV0.74
Discount 58%
Return to IV: +137.0%
Market implies -12.9%/yr
vs model +4.8% · below model
ORI
Fairly valued
OLD REPUBLIC INTERNATIONAL CORP
Price$40.96
Model IV$43.04
P/IV0.87
Discount 5%
Return to IV: +5.1%
ORIC
Valuation N/A
Oric Pharmaceuticals, Inc.
Price$12.04
Model IV—
P/IV—
ORIO
Valuation N/A
Orion Digital Corp.
Price$1.05
Model IV—
P/IV—